Press "Enter" to skip to content

Biden admin moves to avoid shortages of antibody treatments

The US government is buying more doses of monoclonal antibody treatments for Covid-19, and the Biden administration is taking over distribution in order to avoid shortages of the key therapeutics.

The US government is buying more doses of monoclonal antibody treatments for Covid-19, and the Biden administration is taking over distribution in order to avoid shortages of the key therapeutics.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *